155 related articles for article (PubMed ID: 9042239)
1. Enhancement of radiation response of prostatic carcinoma by lonidamine.
Dudak SD; Lopez A; Block NL; Lokeshwar BL
Anticancer Res; 1996; 16(6B):3665-71. PubMed ID: 9042239
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of radiation response of prostatic carcinoma by taxol: therapeutic potential for late-stage malignancy.
Lokeshwar BL; Ferrell SM; Block NL
Anticancer Res; 1995; 15(1):93-8. PubMed ID: 7733649
[TBL] [Abstract][Full Text] [Related]
3. Genistein potentiates the radiation effect on prostate carcinoma cells.
Hillman GG; Forman JD; Kucuk O; Yudelev M; Maughan RL; Rubio J; Layer A; Tekyi-Mensah S; Abrams J; Sarkar FH
Clin Cancer Res; 2001 Feb; 7(2):382-90. PubMed ID: 11234894
[TBL] [Abstract][Full Text] [Related]
4. Paclitaxel enhanced radiation sensitization for the suppression of human prostate cancer tumor growth via a p53 independent pathway.
Zhang AL; Russell PJ; Knittel T; Milross C
Prostate; 2007 Nov; 67(15):1630-40. PubMed ID: 17823933
[TBL] [Abstract][Full Text] [Related]
5. Vitamin D inhibition of prostate adenocarcinoma growth and metastasis in the Dunning rat prostate model system.
Getzenberg RH; Light BW; Lapco PE; Konety BR; Nangia AK; Acierno JS; Dhir R; Shurin Z; Day RS; Trump DL; Johnson CS
Urology; 1997 Dec; 50(6):999-1006. PubMed ID: 9426741
[TBL] [Abstract][Full Text] [Related]
6. [Effects of lonidamine alone or in combination with radiotherapy on survival and metabolism in human and rodent cell lines].
Latz D; Flentje M; Eble M; Hör A; Wannenmacher M
Strahlenther Onkol; 1991 Dec; 167(12):716-22. PubMed ID: 1763408
[TBL] [Abstract][Full Text] [Related]
7. Tumor-targeted apoptosis by a novel spermine analogue, 1,12-diaziridinyl-4,9-diazadodecane, results in therapeutic efficacy and enhanced radiosensitivity of human prostate cancer.
Eiseman JL; Rogers FA; Guo Y; Kauffman J; Sentz DL; Klinger MF; Callery PS; Kyprianou N
Cancer Res; 1998 Nov; 58(21):4864-70. PubMed ID: 9809992
[TBL] [Abstract][Full Text] [Related]
8. Alpha1-adrenoceptor antagonists radiosensitize prostate cancer cells via apoptosis induction.
Cuellar DC; Rhee J; Kyprianou N
Anticancer Res; 2002; 22(3):1673-9. PubMed ID: 12168853
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of intrinsic tumor cell radiosensitivity induced by a selective cyclooxygenase-2 inhibitor.
Petersen C; Petersen S; Milas L; Lang FF; Tofilon PJ
Clin Cancer Res; 2000 Jun; 6(6):2513-20. PubMed ID: 10873107
[TBL] [Abstract][Full Text] [Related]
10. Modulation of cellular radiation responses by 2-deoxy-D-glucose and other glycolytic inhibitors: implications for cancer therapy.
Kalia VK; Prabhakara S; Narayanan V
J Cancer Res Ther; 2009 Sep; 5 Suppl 1():S57-60. PubMed ID: 20009297
[TBL] [Abstract][Full Text] [Related]
11. Role of cell cycle perturbations in the combination therapy of chemotherapeutic agents and radiation.
Pauwels B; Wouters A; Peeters M; Vermorken JB; Lardon F
Future Oncol; 2010 Sep; 6(9):1485-96. PubMed ID: 20919831
[TBL] [Abstract][Full Text] [Related]
12. Apoptosis and clonogenic cell death in PC3 human prostate cancer cells after treatment with gamma radiation and suramin.
Palayoor ST; Bump EA; Teicher BA; Coleman CN
Radiat Res; 1997 Aug; 148(2):105-14. PubMed ID: 9254728
[TBL] [Abstract][Full Text] [Related]
13. Dichloroacetate (DCA) sensitizes both wild-type and over expressing Bcl-2 prostate cancer cells in vitro to radiation.
Cao W; Yacoub S; Shiverick KT; Namiki K; Sakai Y; Porvasnik S; Urbanek C; Rosser CJ
Prostate; 2008 Aug; 68(11):1223-31. PubMed ID: 18465755
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of cyclooxygenase-2 activity by celecoxib does not lead to radiosensitization of human prostate cancer cells in vitro.
Ohneseit PA; Krebiehl G; Dittmann K; Kehlbach R; Rodemann HP
Radiother Oncol; 2007 Feb; 82(2):229-38. PubMed ID: 17207548
[TBL] [Abstract][Full Text] [Related]
15. Does AK-2123 (Senazole) have sensitizing effects on radiation, cisplatin and hyperthermia under aerobic conditions in vitro?
Mitsuhashi N; Sakurai H; Takahashi T; Akimoto T; Higuchi K; Matsumoto H; Ebara T; Nozaki M; Niibe H
Anticancer Res; 1998; 18(5A):3463-7. PubMed ID: 9858925
[TBL] [Abstract][Full Text] [Related]
16. Neutron or photon irradiation for prostate tumors: enhancement of cytokine therapy in a metastatic tumor model.
Hillman GG; Maughan RL; Grignon DJ; Yudelev M; Rubio J; Tekyi-Mensah S; Layer A; Che M; Forman JD
Clin Cancer Res; 2001 Jan; 7(1):136-44. PubMed ID: 11205901
[TBL] [Abstract][Full Text] [Related]
17. Flavopiridol potentiates the cytotoxic effects of radiation in radioresistant tumor cells in which p53 is mutated or Bcl-2 is overexpressed.
Hara T; Omura-Minamisawa M; Kang Y; Cheng C; Inoue T
Int J Radiat Oncol Biol Phys; 2008 Aug; 71(5):1485-95. PubMed ID: 18640498
[TBL] [Abstract][Full Text] [Related]
18. Cytotoxicity of lonidamine alone and in combination with other drugs against murine RIF-1 and human HT1080 cells in vitro.
Ning SC; Hahn GM
Cancer Res; 1990 Dec; 50(24):7867-70. PubMed ID: 2253227
[TBL] [Abstract][Full Text] [Related]
19. The effect of lonidamine (LND) on radiation and thermal responses of human and rodent cell lines.
Raaphorst GP; Feeley MM; Danjoux CE; Martin L; Fisher B; Maroun J; DeSanctis AJ
Int J Radiat Oncol Biol Phys; 1991 Mar; 20(3):509-15. PubMed ID: 1995536
[TBL] [Abstract][Full Text] [Related]
20. An orally active Amazonian plant extract (BIRM) inhibits prostate cancer growth and metastasis.
Dandekar DS; Lokeshwar VB; Cevallos-Arellano E; Soloway MS; Lokeshwar BL
Cancer Chemother Pharmacol; 2003 Jul; 52(1):59-66. PubMed ID: 12734674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
